.Attributes Medication, Released online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- drug conjugate (ADC) tisotumab vedotin caused enhanced progression-free and also total survival, triggering FDA commendation and a new procedure possibility for people.